Rising prostate-specific antigen values during neoadjuvant androgen deprivation therapy: The importance of monitoring

Article ID	Journal	Published Year	Pages	File Type
8246300	International Journal of Radiation OncologyBiologyPhysics	2006	6 Pages	PDF

Abstract

Conclusions:: A subset of patients treated with N-ADT develop a rising PSA profile that likely represents early androgen resistance. They have significantly worse outcome.

Keywords

androgen deprivation therapy Radiotherapy Prostate cancer prostate-specific antigen

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

Rising prostate-specific antigen values during neoadjuvant androgen deprivation therapy: The importance of monitoring

Authors

Paddy B.M., F.R.C.R., Tom M.D., F.R.C.P.C., The British Columbia Cancer Agency Prostate Cohort Outcomes Initiative The British Columbia Cancer Agency Prostate Cohort Outcomes Initiative,